230 related articles for article (PubMed ID: 11305412)
1. Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.
Janss AJ; Maity A; Tang CB; Muschel RJ; McKenna WG; Sutton L; Phillips PC
Neuro Oncol; 2001 Jan; 3(1):11-21. PubMed ID: 11305412
[TBL] [Abstract][Full Text] [Related]
2. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
Hsieh WT; Huang KY; Lin HY; Chung JG
Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
[TBL] [Abstract][Full Text] [Related]
3. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
[TBL] [Abstract][Full Text] [Related]
4. Huanglian, A chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells.
Li XK; Motwani M; Tong W; Bornmann W; Schwartz GK
Mol Pharmacol; 2000 Dec; 58(6):1287-93. PubMed ID: 11093765
[TBL] [Abstract][Full Text] [Related]
5. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells.
Choi YH; Zhang L; Lee WH; Park KY
Int J Oncol; 1998 Aug; 13(2):391-6. PubMed ID: 9664138
[TBL] [Abstract][Full Text] [Related]
6. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
Nomura N; Nomura M; Newcomb EW; Zagzag D
Biochem Pharmacol; 2007 May; 73(10):1528-36. PubMed ID: 17324379
[TBL] [Abstract][Full Text] [Related]
7. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.
O'Connor PM; Ferris DK; Pagano M; Draetta G; Pines J; Hunter T; Longo DL; Kohn KW
J Biol Chem; 1993 Apr; 268(11):8298-308. PubMed ID: 8463339
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
Delmas D; Passilly-Degrace P; Jannin B; Cherkaoui Malki M; Latruffe N
Int J Mol Med; 2002 Aug; 10(2):193-9. PubMed ID: 12119558
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
11. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the G2/M transition by p53.
Taylor WR; Stark GR
Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.
Liu Q; Tao B; Liu G; Chen G; Zhu Q; Yu Y; Yu Y; Xiong H
J Biol Chem; 2016 Feb; 291(9):4779-92. PubMed ID: 26724804
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity.
Dash BC; El-Deiry WS
Mol Cell Biol; 2005 Apr; 25(8):3364-87. PubMed ID: 15798220
[TBL] [Abstract][Full Text] [Related]
15. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
16. Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines.
Suzuki M; Hosaka Y; Matsushima H; Goto T; Kitamura T; Kawabe K
Cancer Lett; 1999 Apr; 138(1-2):121-30. PubMed ID: 10378783
[TBL] [Abstract][Full Text] [Related]
17. [Effects of mangiferin on cell cycle status and CDC2/Cyclin B1 expression of HL-60 cells].
Yao YB; Peng ZG; Liu ZF; Yang J; Luo J
Zhong Yao Cai; 2010 Jan; 33(1):81-5. PubMed ID: 20518311
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.
Hapke G; Yin MB; Wu J; Frank C; Rustum YM
Int J Oncol; 2002 Nov; 21(5):1059-66. PubMed ID: 12370755
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of cyclin B1 and cdc2 expression during 9-nitrocamptothecin-induced regression of DU145 prostate tumor.
Chatterjee D; Wyche JH; Pantazis P
Anticancer Res; 2000; 20(6B):4477-82. PubMed ID: 11205291
[TBL] [Abstract][Full Text] [Related]
20. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.
Tsao YP; D'Arpa P; Liu LF
Cancer Res; 1992 Apr; 52(7):1823-9. PubMed ID: 1312900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
